Gensight Biologics SA (SIGHT) — Strategic Asset Allocation Index
Gensight Biologics SA (SIGHT) has a Strategic Asset Allocation Index of 83.4% as of June 2022. Strategic assets (PP&E of €2.67 Million plus long-term investments of €-) total €2.67 Million, measured against net assets of €3.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Gensight Biologics SA to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Gensight Biologics SA Strategic Asset Allocation Index (2013–2021)
This chart shows how Gensight Biologics SA's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of June 2022, the index stands at 83.4%, representing strategic assets of €2.67 Million against net assets of €3.20 Million EUR. For live market cap and overall valuation, see Gensight Biologics SA market cap and net worth.
Annual Strategic Asset Allocation Index for Gensight Biologics SA (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Gensight Biologics SA from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Gensight Biologics SA net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 15.9% | €2.55 Million | €2.55 Million | €- | €15.99 Million | ▼ -11.1 pp |
| 2020 | 27.0% | €3.15 Million | €3.15 Million | €- | €11.67 Million | ▼ -9.0 pp |
| 2019 | 36.0% | €4.23 Million | €4.23 Million | €- | €11.75 Million | ▲ +30.1 pp |
| 2018 | 5.8% | €1.40 Million | €1.40 Million | €- | €23.87 Million | ▲ +4.2 pp |
| 2017 | 1.6% | €889.00K | €889.00K | €- | €55.00 Million | ▲ +0.0 pp |
| 2016 | 1.6% | €858.00K | €858.00K | €- | €53.34 Million | ▼ -1.3 pp |
| 2015 | 2.9% | €860.96K | €860.96K | €- | €29.33 Million | ▲ +0.3 pp |
| 2014 | 2.6% | €278.00K | €278.00K | €- | €10.58 Million | ▲ +0.7 pp |
| 2013 | 1.9% | €325.00K | €325.00K | €- | €16.97 Million | — |